期刊
TRENDS IN MOLECULAR MEDICINE
卷 26, 期 1, 页码 8-20出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2019.07.002
关键词
-
资金
- HELSE SoR-OST [2017056]
- Research Council of Norway [262175, 277813]
- Akershus University Hospital Strategic grant [269901]
- AXA Research Fund post-doctoral long-term fellowship
- Hellenic Foundation for Research and Innovation (HFRI)
- General Secretariat for Research and Technology (GSRT)
- European Research Council [ERC GA695190 - MANNA]
- European Commission Framework Programmes
- Greek Ministry of Education
Neurodegenerative diseases are strongly age-related and currently cannot be cured, with a surge of patient numbers in the coming decades in view of the emerging worldwide ageing population, bringing healthcare and socioeconomic challenges. Effective therapies are urgently needed, and are dependent on new aetiological mechanisms. In neurons, efficient clearance of damaged mitochondria, through the highly evolutionary conserved cellular process termed mitophagy, plays a fundamental role in mitochondrial and metabolic homeostasis, energy supply, neuronal survival, and health. Conversely, defective mitophagy leads to accumulation of damaged mitochondria and cellular dysfunction, contributing to ageing and age-predisposed neurodegeneration. Here, we discuss the contribution of defective mitophagy in these diseases, and underlying molecular mechanisms, and highlight novel therapeutics based on new discovered mitophagy-inducing strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据